Fang Niu

ORCID: 0009-0004-3439-7410
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Biosimilars and Bioanalytical Methods
  • Health Systems, Economic Evaluations, Quality of Life
  • Blood Pressure and Hypertension Studies
  • Cancer Immunotherapy and Biomarkers
  • Pharmaceutical studies and practices
  • Pharmaceutical Practices and Patient Outcomes
  • Cardiac Arrhythmias and Treatments
  • Medication Adherence and Compliance
  • Bone health and osteoporosis research
  • Bone health and treatments
  • Drug-Induced Hepatotoxicity and Protection
  • Gout, Hyperuricemia, Uric Acid
  • Colorectal Cancer Treatments and Studies
  • Economic and Financial Impacts of Cancer
  • Lung Cancer Treatments and Mutations
  • Venous Thromboembolism Diagnosis and Management
  • Hormonal Regulation and Hypertension
  • Reproductive Health and Contraception
  • Cardiac electrophysiology and arrhythmias
  • Pharmacovigilance and Adverse Drug Reactions
  • CAR-T cell therapy research
  • Ovarian cancer diagnosis and treatment
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Microscopic Colitis

Kaiser Permanente
2015-2025

Shanghai Traditional Chinese Medicine Hospital
2020-2024

University of California, San Francisco
2019

University of Washington
2019

Western University of Health Sciences
2015

Analytical Services
2009-2014

Imperial Valley College
2014

Los Angeles Medical Center
2010-2011

People’s Hospital of Rizhao
2011

University of California, Los Angeles
2006

Controversy exists regarding the safety of testosterone replacement therapy (TRT) following recent reports an increased risk adverse cardiovascular events.To investigate association between TRT and outcomes in men with androgen deficiency.A retrospective cohort study was conducted within integrated health care delivery system. Men at least 40 years old evidence deficiency either by a coded diagnosis and/or morning serum total level less than 300 ng/dL were included. The eligibility window...

10.1001/jamainternmed.2016.9546 article EN JAMA Internal Medicine 2017-02-27

Objective. To evaluate the association between hyperuricemia and renal disease progression in a real-world, large observational database study. Methods. We conducted population-based retrospective cohort study identifying 111,992 patients with (> 7 mg/dl) from medical group. The final were ≥ 18 years old, urate-lowering therapy (ULT)-naïve, had following laboratory results available: at least 1 glomerular filtration rate (GFR) level before index date serum uric acid (sUA) GFR followup...

10.3899/jrheum.131159 article EN The Journal of Rheumatology 2014-04-01

Abstract Objective To describe the quality of osteoarthritis care provided to community‐dwelling elderly patients and characterize arthritis‐related function in these patients. Methods Two medical groups western United States participated a practice‐redesign intervention targeted at falls mobility disorders, incontinence, cognitive impairment, but not osteoarthritis. From 339 individuals reporting diagnosis arthritis, we collected information on demographics, functional status, via patient...

10.1002/art.21844 article EN Arthritis Care & Research 2006-03-31

Primary nonadherence to a medication occurs when drug is prescribed but the patient fails pick prescription up from pharmacy. Managed care organizations that provide integrated using electronic medical records (EMR) are an ideal setting study primary nonadherence. To identify and provider characteristics significantly associated with statin medications compared population of patients who picked their first order. This was retrospective cohort new prescription. Patients order for between...

10.18553/jmcp.2013.19.5.367 article EN Journal of Managed Care Pharmacy 2013-06-01

Background: The interaction between warfarin and nonsteroidal antiinflammatory drugs (NSAIDs) is well known. However, NSAIDs are still commonly prescribed together. Selective cyclooxygenase-2 (COX-2) inhibitors, a newer class of NSAID, offer potential advantages over the nonselective in patients treated with warfarin. Objective: To study rates hospitalization for gastrointestinal (GI) bleeding events 3 groups patients: those taking only, plus selective COX-2 inhibitor. Methods: This was...

10.1345/aph.1m284 article EN Annals of Pharmacotherapy 2009-10-06

Purpose: (1) To assess long-term adherence to American Diabetes Association guideline-recommended retinal screening among population with diabetes in the United States. (2) determine factors associated routine eye exams.Methods: A retrospective cohort study was conducted adult patients identified from January 2009 December 2010. Patients were followed until disenrollment, death, or end date (December 2013). patient defined as adherent when having at least one exam each 12-month period if...

10.1080/09286586.2018.1424344 article EN Ophthalmic Epidemiology 2018-01-15

Importance It is unclear whether the effects of intensive vs standard blood pressure (BP) targets seen in clinical trials generalize to patients with chronic kidney disease (CKD) encountered everyday practice due differences distribution cardiovascular risk factors and coexisting conditions. Objective To evaluate beneficial adverse BP control observed Systolic Blood Pressure Intervention Trial (SPRINT) are transportable a target population adults CKD practice. Design, Setting, Participants...

10.1001/jamanetworkopen.2024.53458 article EN cc-by-nc-nd JAMA Network Open 2025-01-07

Objectives Concomitant use of cytochrome P-450 and P-glycoprotein (CYP 3A4/P-gp) inducing antiseizure medications direct oral anticoagulants (DOAC) may result in reduced DOAC effectiveness, but study results are inconsistent variable quality. The purpose this was to assess the safety concomitant CYP 3A4/P-gp use. Methods This a retrospective cohort adult patients who were newly, concomitantly receiving (apixaban, dabigatran, or rivaroxaban) either inducer (carbamazepine, phenytoin,...

10.1097/mbc.0000000000001342 article EN Blood Coagulation & Fibrinolysis 2025-01-23

There may be patient concerns with switching to a biosimilar product. The purpose of this study was describe the perspectives patients inflammatory bowel diseases (IBD) after from reference product (RP) adalimumab adalimumab-atto. This telephonic survey US IBD conducted in June-July 2023 among adult, English-speaking who were switched adalimumab-atto RP within previous 100 days, and receiving at time survey. Consented participants queried on safety effectiveness, cost, preference, education...

10.1080/14712598.2025.2488222 article EN Expert Opinion on Biological Therapy 2025-04-01

To examine the associations between lowering low-density lipoprotein cholesterol (LDL-C) and cardiovascular (CV) outcomes among patients with rheumatoid arthritis (RA) without it.Adult RA 2 age- sex-matched control cohorts [RA plus general controls (RA/GN), osteoarthritis (OA) (RA/OA)] were identified January 1, 2007, December 31, 2011. Patients a diagnosis of hyperlipidemia who initiated statin therapy prior CV events included. Multivariable Cox proportional hazard analyses used.The study...

10.3899/jrheum.160110 article EN The Journal of Rheumatology 2016-09-01

BACKGROUND: In the elderly, use of medications may increase propensity for adverse drug events due to alterations in pharmacokinetic and pharmacodynamic profiles from normal aging processes. Deprescribing is planned supervised process dose reduction or discontinuation that lead harm are no longer beneficial. While there studies detailing strategies deprescribe such as benzodiazepines antipsychotics nursing homes patients with dementia, a lack guidance safely chronic medications,...

10.18553/jmcp.2019.25.8.927 article EN Journal of Managed Care & Specialty Pharmacy 2019-07-26

ABSTRACT Purpose The aim of this study was to develop an automated causality assessment algorithm identify drug‐induced liver injury. Methods Roussel Uclaf Causality Assessment Method (RUCAM) is for determining the causal association between a drug and In collaboration with hepatology experts, definitions were developed RUCAM criteria operationalize electronic (eRUCAM). eRUCAM tested in population patients taking 14 drugs characteristic phenotype Quality assurance programming specifications...

10.1002/pds.3531 article EN Pharmacoepidemiology and Drug Safety 2013-10-21

The aim was to compare outcomes in adult patients with inflammatory bowel disease (IBD) who switched infliximab-dyyb those remained on reference product (RP) infliximab the United States (US) a retrospective, propensity score-matched, non-inferiority cohort trial. This study conducted within US integrated healthcare system and included confirmed diagnosis of Crohn's or ulcerative colitis. A 1:1 score matching utilized match during period April 2016–March 2018 RP infliximab. margin set at +...

10.1007/s40259-020-00409-y article EN cc-by-nc BioDrugs 2020-02-26

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat symptoms of chronic inflammatory diseases such as osteoarthritis and rheumatoid arthritis; however, they also associated with various adverse effects, including gastrointestinal (GI) bleeding renal harm. As patients get older, some medications may no longer be beneficial or even cause Deprescribing is defined the planned supervised process dose reduction discontinuation medications. While there studies showing that...

10.18553/jmcp.2020.26.7.918 article EN Journal of Managed Care & Specialty Pharmacy 2020-06-25

The quality of antithrombotic therapy for patients with nonvalvular atrial fibrillation during routine medical care is often suboptimal. Evidence linking stroke and bleeding risk treatment limited. purpose this study was to evaluate the associations between episodes outcomes.

10.1161/jaha.115.001921 article EN cc-by-nc-nd Journal of the American Heart Association 2015-07-17

Warfarin is a common treatment option to manage patients with nonvalvular atrial fibrillation (NVAF) in clinical practice. Understanding current pharmacist-led anticoagulation clinic management patterns and associated outcomes important for quality improvement; however, currently little evidence associating exists.To (a) describe warfarin (b) evaluate associations between NVAF an integrated health care system.A retrospective cohort study was conducted among therapy January 1, 2006, December...

10.18553/jmcp.2017.23.6.700 article EN Journal of Managed Care & Specialty Pharmacy 2017-05-22

Mineralocorticoid receptor antagonist (MRA) when combined with either angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin blockers (ARBs) may provide additional benefits of cardiovascular and kidney disease risk reduction in patients diabetic (DKD) hypertension. We evaluated the effectiveness combination therapy (MRAs, spironolactone eplerenone, plus ACEI/ARB) compared monotherapy (ACEI/ARB only) DKD hypertension.Retrospective cohort study was performed (age ≥ 18 years)...

10.1002/phar.2633 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2021-10-16

Examining drug exposure is essential to pharmacovigilance, especially for bisphosphonate (BP) therapy.To examine differences in 4 measures of oral BP exposure: treatment discontinuation, adherence, persistence, and nonpersistence.Among women aged ≥ 50 years who initiated therapy during 2002-2007 with at least 3 health plan membership follow-up, discontinuation was defined by evidence no further the study observation period. Among those 2 filled prescriptions period, adherence calculated each...

10.18553/jmcp.2017.23.4.503 article EN Journal of Managed Care & Specialty Pharmacy 2017-03-25

<h3>Importance</h3> Clinical trials have demonstrated the antifracture efficacy of bisphosphonate drugs for first 3 to 5 years therapy. However, continuing as long 10 is uncertain. <h3>Objective</h3> To examine association discontinuing at study entry, 2 years, and additional with risk hip fracture among women who had completed treatment entry. <h3>Design, Setting, Participants</h3> This cohort included were members Kaiser Permanente Northern Southern California, integrated health care...

10.1001/jamanetworkopen.2020.25190 article EN cc-by-nc-nd JAMA Network Open 2020-12-07

Baclofen and tizanidine are both muscle relaxants that carry the risk for neuropsychiatric events in older adults but there is a lack of data directly comparing their safety. This study aimed to investigate relative between these two medications causing injury delirium adults.This was retrospective cohort completed an integrated healthcare system United States included patients aged 65 years or who started baclofen treatment musculoskeletal pain from January 2016 through December 2018....

10.1111/jgs.18349 article EN Journal of the American Geriatrics Society 2023-03-29
Coming Soon ...